Susquehanna International Group, LLP Celularity Inc Call Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$0.17 - $0.33 $136 - $264	800 Added 0.28%	286,700 $71,000
Q1 2023 May 16, 2023	SELL	$0.56 - $1.15 $145,320 - $298,425	-259,500 Reduced 47.58%	285,900 $177,000
Q4 2022 Feb 14, 2023	SELL	$1.08 - $2.35 $198,396 - $431,695	-183,700 Reduced 25.2%	545,400 $703,000
Q3 2022 Nov 14, 2022	SELL	$0.43 - $4.31 $79,077 - $792,608	-183,900 Reduced 20.14%	729,100 $1.68 Million
Q2 2022 Aug 15, 2022	BUY	$2.81 - $12.91 $309,100 - $1.42 Million	110,000 Added 13.7%	913,000 $3.1 Million
Q1 2022 May 16, 2022	BUY	$3.81 - $9.79 $1.57 Million - $4.04 Million	413,100 Added 105.95%	803,000 $6.99 Million
Q4 2021 Feb 14, 2022	SELL	$4.64 - $7.46 $1.19 Million - $1.91 Million	-256,100 Reduced 39.64%	389,900 $2 Million
Q3 2021 Nov 15, 2021	BUY	$6.05 - $12.15 $3.91 Million - $7.85 Million	646,000 New	646,000 $4.57 Million

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.